bioMérieux
A global leader in in vitro diagnostics for clinical and industrial applications.
BIM | PA
Overview
Corporate Details
- ISIN(s):
- FR0013280286 (+13 more)
- LEI:
- 549300AK8Y0LBIQ4T071
- Country:
- France
- Address:
- 376 CHE DE L'ORME, 69280 MARCY-L'ETOILE
- Website:
- https://www.biomerieux.com/
- Sector:
- Manufacturing
Description
bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-02 15:44 |
Novembre 2025 - Déclaration sur le nombre d'actions composant le capital social…
|
French | 108.1 KB | ||
| 2025-11-04 11:17 |
Octobre 2025 - Déclaration sur le nombre d'actions composant le capital social …
|
French | 108.2 KB | ||
| 2025-09-02 11:11 |
Août 2025 - Déclaration sur le nombre d'actions composant le capital social et …
|
French | 106.1 KB | ||
| 2025-08-05 09:41 |
Juillet 2025 - Déclaration sur le nombre d'actions composant le capital social …
|
French | 105.8 KB | ||
| 2025-06-16 07:01 |
bioMérieux strengthens its next-generation sequencing capabilities with the acq…
|
English | 222.9 KB | ||
| 2025-06-16 07:01 |
bioMérieux renforce ses capacités de séquençage de nouvelle génération avec l’a…
|
French | 248.3 KB | ||
| 2025-06-03 16:05 |
Mai 2025 - Déclaration sur le nombre d'actions composant le capital social et s…
|
French | 106.1 KB | ||
| 2025-06-03 07:01 |
bioMérieux launches cutting-edge equine infectious respiratory disease testing
|
English | 276.4 KB | ||
| 2025-06-03 07:01 |
bioMérieux lance un test diagnostic innovant pour détecter les maladies respira…
|
French | 274.0 KB | ||
| 2025-05-05 11:37 |
Avril 2025 - Déclaration sur le nombre d'actions composant le capital social et…
|
French | 106.1 KB | ||
| 2025-04-22 07:01 |
WATCHFIRE™ by bioMérieux: a PCR test to detect viruses and bacteria in wastewat…
|
English | 277.8 KB | ||
| 2025-04-22 07:01 |
WATCHFIRE™, un nouveau test PCR développé par bioMérieux pour détecter les viru…
|
French | 267.8 KB | ||
| 2025-04-17 07:01 |
bioMérieux – First-Quarter 2025 Business Review
|
English | 325.6 KB | ||
| 2025-04-17 07:01 |
bioMérieux – Information financière du 1er trimestre 2025
|
French | 281.7 KB | ||
| 2025-04-07 07:01 |
bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solutio…
|
English | 276.6 KB |
Automate Your Workflow. Get a real-time feed of all bioMérieux filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for bioMérieux
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for bioMérieux via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-04 | N/A | Other | Sell | 1,432 | 137,517.82 EUR |
| 2023-09-04 | N/A | Other | Sell | 1,253 | 120,328.10 EUR |
| 2023-09-01 | N/A | Other | Other | 2,900 | N/A |
| 2023-06-23 | N/A | Other | Other | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 300 | 23,193.00 EUR |
| 2023-06-23 | N/A | Other | Buy | 25 | 1,932.75 EUR |
| 2023-03-23 | N/A | Other | Sell | 16,500 | 1,650,415.80 EUR |
Peer Companies
